XML 65 R7.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 6 Months Ended 12 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Cash flows – operating activities:          
Net loss $ (1,794) $ (574) $ (2,242) $ (5,053) $ (4,290)
Non-cash items –          
Share-based plans expense 208 381 690 725 833
Treasury shares issued for 401(k) contribution 953 862 1,515 1,215 1,233
Depreciation and amortization 883 913 1,861 1,979 2,144
Investment/asset impairment charges, net 34 12 46 112 98
Gain on dispositions, net (5) (1) (2) (6) (277)
787 reach-forward loss         3,460
Other charges and credits, net (34) 30 3 401 360
Changes in assets and liabilities –          
Accounts receivable (522) (433) (128) 142 (713)
Unbilled receivables (1,345) (721) 321 6 (586)
Advances and progress billings 1,886 2,228 3,365 108 2,505
Inventories (5,937) (241) (1,681) 420 (1,127)
Other current assets (320) 313 389 (591) 345
Accounts payable (222) 852 1,672 838 (3,783)
Accrued liabilities (443) (399) 779 2,956 (3,687)
Income taxes receivable, payable and deferred (188) (424) 44 1,347 733
Other long-term liabilities (148) (180) (313) (158) (206)
Pension and other postretirement plans (491) (520) (1,049) (1,378) (972)
Financing receivables and operating lease equipment, net 149 419 571 142 210
Other 51 40 119 307 304
Net cash (used)/provided by operating activities (7,285) 2,557 5,960 3,512 (3,416)
Cash flows – investing activities:          
Payments to acquire property, plant and equipment (971) (764) (1,527) (1,222) (980)
Proceeds from disposals of property, plant and equipment 30 13 27 35 529
Acquisitions, net of cash acquired (50)   (70)   (6)
Contributions to investments (1,617) (9,496) (16,448) (5,051) (35,713)
Proceeds from investments 3,173 5,567 15,739 10,619 45,489
Supplier notes receivable (486) (162)      
Purchase of distribution rights (88)        
Other (17) 4 (158) (11) 5
Net cash used by investing activities (26) (4,838) (2,437) 4,370 9,324
Cash flows – financing activities:          
New borrowings 10,089 38 75 34 9,795
Debt repayments (4,481) (5,123) (5,216) (1,310) (15,371)
Stock options exercised   44 45 50 42
Employee taxes on certain share-based payment arrangements (67) (48) (408) (40) (66)
Other (3) (4) 17    
Net cash provided/(used) by financing activities 5,538 (5,093) (5,487) (1,266) (5,600)
Effect of exchange rate changes on cash and cash equivalents (25) 2 30 (73) (39)
Net (decrease)/increase in cash & cash equivalents, including restricted (1,798) (7,372) (1,934) 6,543 269
Cash & cash equivalents, including restricted, at beginning of year 12,713 14,647 14,647 8,104 7,835
Cash & cash equivalents, including restricted, at end of period 10,915 7,275 12,713 14,647 8,104
Less restricted cash & cash equivalents, included in Investments 21 21 22 33 52
Cash and cash equivalents at end of period $ 10,894 $ 7,254 $ 12,691 $ 14,614 $ 8,052